National Institute for Health and Care Excellence

Mirvetuximab soravtansine for treating folate receptor-alpha-positive platinum-resistant ...

There is a simple discount patient access scheme for mirvetuximab soravtansine. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...